The city of St Louis, Missouri, currently has 1 active clinical trials seeking participants for Multiple Sclerosis research studies.
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Recruiting
This study will evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of a new dosage of ofatumumab compared to the approved dosage of ofatumumab followed by extended treatment in participants with relapsing multiple sclerosis.
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
08/14/2025
Locations: WA Uni School Of Med, St Louis, Missouri
Conditions: Relapsing Multiple Sclerosis (RMS)